This study will examine the effect of a healthy diet containing 2 eggs per day compared to a healthy diet containing 3 eggs per week on biomarkers of heart health after 4 weeks.
This is a 2-period, randomized, crossover, controlled feeding study examining the effect of 2020-2025 Dietary Guidelines for Americans adherent dietary patterns containing 2 eggs/day/2000 kcal (HD+E) compared to 3 eggs/week/2000 kcal (HD) on biomarkers of cardiovascular health and function after 4 weeks.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
65
Whole Large, Grade A Egg
The Pennylvania State University
University Park, Pennsylvania, United States
RECRUITINGLDL-cholesterol change
Assessed from fasting blood draw expressed in mg/dL. LDL-cholesterol will be measured directly via enzymatic assay. Change in LDL-cholesterol will be calculated as the mean of the end of diet measures (i.e., mean of day 1 and day 2 values) minus the mean of the baseline measures (i.e., mean of day 1 and day 2 values).
Time frame: 4 weeks
Triglyceride change
Assessed from fasting blood draw expressed in mg/dL.
Time frame: 4 weeks
Total cholesterol change
Assessed from fasting blood draw expressed in mg/dL.
Time frame: 4 weeks
HDL-cholesterol change
Assessed from fasting blood draw expressed in mg/dL.
Time frame: 4 weeks
LDL-cholesterol to HDL-cholesterol ratio change
LDL-cholesterol and HDL-cholesterol will be measured from a fasting blood draw expressed in mg/dL. The ratio will be calculated as LDL-C divided by HDL-C
Time frame: 4 weeks
Change in particle size and number of LDL, HDL, VLDL and chylomicrons
Measured via Nuclear Magnetic Resonance
Time frame: 4 weeks
Change in central systolic and diastolic blood pressure
Blood pressure measured assessed using a SphymoCor Xcel (Atcor Medical)
Time frame: 4 weeks
Change in brachial systolic and diastolic blood pressure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Blood pressure measured assessed using a SphymoCor Xcel (Atcor Medical)
Time frame: 4 weeks
Change in fasting serum insulin
Serum insulin levels assessed in a fasting blood draw and expressed in micro IU/ml
Time frame: 4 weeks
Change in fasting plasma glucose concentration
Glucose assessed in a fasting blood draw and expressed in mg/dL
Time frame: 4 weeks
Change in Fructosamine
Fructosamine assess in a fasting blood draw and expressed in micro IU/ml
Time frame: 4 weeks
Change in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)
Calculated from insulin and glucose measured from a fasting blood sample. Calculated as (insulin × glucose) / 22.5
Time frame: 4 weeks
Change in carotid-femoral pulse wave velocity
A measure of arterial stiffness assessed using a SphymoCor Xcel (Atcor Medical). Expressed in meters/second.
Time frame: 4 weeks
Change in trimethylamine N-oxide (TMAO)
Measured in fasting blood. Expressed as µmol/L
Time frame: 4 weeks
Change in choline
Measured in fasting blood. Expressed as µmol/L
Time frame: 4 weeks
Change in carnitine
Measured in fasting blood. Expressed as µmol/L
Time frame: 4 weeks